BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 18547692)

  • 1. Use of allogenic acellular dermal matrix in prevention of Frey's syndrome after parotidectomy.
    Ye WM; Zhu HG; Zheng JW; Wang XD; Zhao W; Zhong LP; Zhang ZY
    Br J Oral Maxillofac Surg; 2008 Dec; 46(8):649-52. PubMed ID: 18547692
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The use of acellular dermis in the prevention of Frey's syndrome.
    Govindaraj S; Cohen M; Genden EM; Costantino PD; Urken ML
    Laryngoscope; 2001 Nov; 111(11 Pt 1):1993-8. PubMed ID: 11801985
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complications of superficial parotidectomy versus extracapsular lumpectomy in the treatment of benign parotid lesions.
    Prichard AJ; Barton RP; Narula AA
    J R Coll Surg Edinb; 1992 Jun; 37(3):155-8. PubMed ID: 1328626
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional superficial parotidectomy.
    Zhao K; Qi DY; Wang LM
    J Oral Maxillofac Surg; 1994 Oct; 52(10):1038-41. PubMed ID: 8089788
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Advantage of lifting in parotidectomy].
    Marchal F; Sacoun A; Pieyre JM
    Schweiz Med Wochenschr; 2000; Suppl 125():116S-121S. PubMed ID: 11141924
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A new concept in the treatment of Frey's syndrome: the use of interpositional dermal grafts. An experimental study in the dog.
    Cassady CL
    Laryngoscope; 1977 Jun; 87(6):962-74. PubMed ID: 325313
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Post-parotidectomy Frey's syndrome. Treatment with botulinum toxin type A].
    Cavalot AL; Palonta F; Preti G; Nazionale G; Ricci E; Staffieri A; Di Girolamo S; Cortesina G
    Acta Otorhinolaryngol Ital; 2000 Jun; 20(3):187-91. PubMed ID: 11139877
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Frey's syndrome: prevention with conservative parotidectomy and superficial musculoaponeurotic system preservation.
    Yu LT; Hamilton R
    Ann Plast Surg; 1992 Sep; 29(3):217-22. PubMed ID: 1326250
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Botulinum toxoid in the management of gustatory sweating (Frey's syndrome) after superficial parotidectomy.
    Birch JF; Varma SK; Narula AA
    Br J Plast Surg; 1999 Apr; 52(3):230-1. PubMed ID: 10474477
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The role of SMAS in the prevention of Frey's syndrome].
    Belli E; Valentini V; Matteini C
    Minerva Stomatol; 1996 Dec; 45(12):569-74. PubMed ID: 9026702
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Gustatory sweating following parotidectomy. Frey's syndrome].
    Hüttenbrink KB; Hüttenbrink B
    Laryngol Rhinol Otol (Stuttg); 1986 Mar; 65(3):130-4. PubMed ID: 3713389
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevention of Frey's syndrome and volume deficit after parotidectomy using the superficial temporal artery fascial flap.
    Ahmed OA; Kolhe PS
    Br J Plast Surg; 1999 Jun; 52(4):256-60. PubMed ID: 10624290
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of acellular dermal matrix on the prevention of complications and esthetic outcome after parotidectomy: A propensity score matched analysis.
    Wu JH; Zeng W; Fu MY; Ye F
    Ear Nose Throat J; 2024 Jun; 103(6):344-350. PubMed ID: 34814772
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Development and results of surgical treatment of pleomorphic adenoma of the parotid gland in 245 patients, 1974-1994].
    Leverstein H; van der Wal JE; Tiwari RM; van der Waal I; Snow GB
    Ned Tijdschr Geneeskd; 1996 Sep; 140(36):1812-6. PubMed ID: 8927143
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Total conservative parotidectomy for primary benign pleomorphic adenoma of the parotid gland: a 25-year experience with 229 patients.
    Laccourreye H; Laccourreye O; Cauchois R; Jouffre V; Ménard M; Brasnu D
    Laryngoscope; 1994 Dec; 104(12):1487-94. PubMed ID: 7990639
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison of one hundred and fifty consecutive parotidectomies for tumours and inflammatory disease.
    Moody AB; Avery CM; Taylor J; Langdon JD
    Int J Oral Maxillofac Surg; 1999 Jun; 28(3):211-5. PubMed ID: 10355945
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Variation's in the use of SMAS (superficial musculoaponeurotic system) to prevent Frey's syndrome after parotidectomy.
    Moulton-Barrett R; Allison G; Rappaport I
    Int Surg; 1996; 81(2):174-6. PubMed ID: 8912087
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Indications and effects of the SMAS in parotid surgery].
    Bischofberger A; Linder T; Melik N; Schmid S
    Schweiz Med Wochenschr; 2000; Suppl 125():112S-115S. PubMed ID: 11141923
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Surgery in benign parotid tumors: individually adapted or standardized radical interventions?].
    Rehberg E; Schroeder HG; Kleinsasser O
    Laryngorhinootologie; 1998 May; 77(5):283-8. PubMed ID: 9644676
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Frey syndrome after lateral parotidectomy. Follow-up and therapeutic outlook].
    Küttner C; Berens A; Tröger M; Keil C; Eckardt A
    Mund Kiefer Gesichtschir; 2001 Mar; 5(2):144-9. PubMed ID: 11372182
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.